secwatch.observer — SEC 8-K summary
======================================

Issuer:     TherapeuticsMD, Inc. (TXMD)
CIK:        0000025743
Form:       8-K
Filed at:   2022-06-03T23:59:59+00:00
Accession:  0001564590-22-022465
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TherapeuticsMD signs merger agreement with Athene Parent for cash tender offer and merger
--------------------------------------------------------------------------------

- Merger Agreement dated May 27, 2022 with Athene Parent, Inc. and Athene Merger Sub, Inc.
- Cash tender offer to acquire all outstanding TXMD common shares, followed by a merger.
- Board amended bylaws to exempt the transaction from Nevada's control share acquisition statute.
- No deal price, premium, or expected closing date disclosed in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/25743/000156459022022465/0001564590-22-022465-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/25743/000156459022022465/txmd-8k_20220527.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-022465

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer